Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid

A technology of corticosteroids, preparations, applied in the field of treatment of lung diseases and disorders

Active Publication Date: 2007-06-06
CYDEX PHARMACEUTICALS INC
View PDF43 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

And the prior art does not suggest that one cyclodextrin-corticosteroid inhalable formulation would be advantageous over another cyclodextrin-corticosteroid inhalable formulation

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
  • Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
  • Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

Embodiment 2

Embodiment 3

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

An inhalable formulation containing SEA-gamma-CD and corticosteroid is provided. The formulation is adapted for administration to a subject by nebulization with any known nebulizer. The formulation can be included in a kit. The formulation is administered as an aqueous solution, however, it can be stored as a dry powder, ready-to-use solution, or concentrated composition. The formulation is employed in an improved nebulization system for administering corticosteroid by inhalation. SAE-gamma-CD present in the formulation significantly enhances the chemical stability of budesonide. A method of administering the formulation by inhalation is provided. The formulation can also be administered by conventional nasal delivery apparatus.

Description

Inhalation formulations containing sulfoalkyl ether cyclodextrins and corticosteroids Inventors: JamesD.Pipkin, RupertO.Zimmerer, DianeO.Thompson, GeroldL.Mosher technical field The present invention relates to a method and formulation for administering sulfoalkyl ether cyclodextrins and corticosteroids such as budesonide by inhalation. The present invention also relates to methods of treating pulmonary diseases and conditions. Background technique Drug delivery by inhalation results in drug deposition in various parts of the respiratory tract, such as the throat, trachea, bronchi, and alveoli. In general, the smaller the particle size, the longer the particles remain suspended in the air, so the drug can be delivered deeper into the respiratory tract. Corticosteroids are delivered by inhalation using a nebulizer, metered dose inhaler, or dry powder inhaler. The main advantages of nebulizers are that they do not require patient cooperation and are simpler to deliver hi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/12A61K45/06C08B37/16A61K9/00A61K9/08A61K9/14A61K31/16A61K31/57A61K31/715A61K47/40A61K47/48
CPCA61K9/0078A61K31/16A61K47/48969A61K31/57A61K47/40A61K31/715B82Y5/00A61K9/08A61K9/0075A61K31/573A61K47/6951A61K31/137A61K31/167A61K31/46A61K31/56A61K31/58A61P11/00A61P11/06A61P29/00A61P43/00A61K2300/00A61K9/00
Inventor 詹姆斯·D.·皮普金鲁珀特·O.·齐默勒戴安娜·O.·汤普森格罗尔德·L.·莫舍
Owner CYDEX PHARMACEUTICALS INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap